Z-2301-2020 Class II Terminated

Recalled by Immuno-Mycologics, Inc — Norman, OK

FDA device recall Z-2301-2020 was initiated by Immuno-Mycologics, Inc on Nov 4, 2019 and is designated Class II. Reason for recall: False positive results due to potential contamination of reagent. The recall status is terminated (terminated May 27, 2022). Affected quantity: 155 vials.

Recall details

Product Type
Devices
Report Date
Jun 17, 2020
Initiation Date
Nov 4, 2019
Termination Date
May 27, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
155 vials

Product description

Histoplasma Immunodiffusion (ID) Antigen; The IFU labeling is for multiple products which included Fungal Antigens, Positive Controls and ID Plates,and Immunodiffusion (ID) Plates for use in the ID Test, Histoplasma ID Antigen

Reason for recall

False positive results due to potential contamination of reagent.

Distribution pattern

Worldwide distribution - US Nationwide distribution including in the states of AZ, CA, FL, IL, IN, MI, MN, NY,TX, UT, VA, WI and the countries of France, Spain, Hong Kong, United Kingdom.

Code information

Lot number L106909; UDI # (01) 00816387020391 (17) 220610(10)L106909

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2301-2020
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2301-2020. Report a data issue: hello@regdatalab.com.